Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (141-150 of 668) with videos related to

Pageof 67
Sort By:
Gastroenterologia Y Hepatologia|March 22, 2007
[Role of biological markers in inflammatory bowel disease]Javier P Gisbert, Yago González-Lama, José Maté
Gastroenterologia Y Hepatologia|August 30, 2006
[Vascular development in inflammatory bowel disease]Inés D Pousa, Javier P Gisbert, José Maté
Gastroenterologia Y Hepatologia|March 30, 2016
Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel diseasePablo Miranda-García, María Chaparro, Javier P Gisbert
Journal of Crohn'S & Colitis|January 18, 2023
Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A ReviewJavier P Gisbert, María José García, María Chaparro
Alimentary Pharmacology & Therapeutics|June 9, 2025
Editorial: Time to EXIT? When Less Is More in IBD Management. Authors' ReplyMaría José Casanova, María Chaparro, Javier P Gisbert
Inflammation & Allergy Drug Targets|November 1, 2012
Pathophysiological bases of eosinophilic esophagitis therapyRicardo Moreno-Borque, Javier P Gisbert, Cecilio Santander
Gastroenterologia Y Hepatologia|November 28, 2020
Epidemiological and clinical characteristics, and response to treatment in 113 patients with microscopic colitisEukene Rojo, María José Casanova, Javier P Gisbert
Alimentary Pharmacology & Therapeutics|June 7, 2024
Letter: Third-line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions-Authors' replyMaría José García, Javier P Gisbert, María Chaparro
Digestive Diseases and Sciences|September 12, 2006
The role of tacrolimus in inflammatory bowel disease: a systematic reviewYago Gonzalez-Lama, Javier P Gisbert, Jose Mate
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2025
Author's Reply: "Ustekinumab and vedolizumab: A step forward in managing complex perianal fistulas in Crohn's disease"María José Casanova, María Chaparro, Javier P Gisbert
Pageof 67

Showing results (141-150 of 668) with videos related to

Sort By:
Pageof 67
Gastroenterologia Y Hepatologia|March 22, 2007
[Role of biological markers in inflammatory bowel disease]Javier P Gisbert, Yago González-Lama, José Maté
Gastroenterologia Y Hepatologia|August 30, 2006
[Vascular development in inflammatory bowel disease]Inés D Pousa, Javier P Gisbert, José Maté
Gastroenterologia Y Hepatologia|March 30, 2016
Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel diseasePablo Miranda-García, María Chaparro, Javier P Gisbert
Journal of Crohn'S & Colitis|January 18, 2023
Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A ReviewJavier P Gisbert, María José García, María Chaparro
Alimentary Pharmacology & Therapeutics|June 9, 2025
Editorial: Time to EXIT? When Less Is More in IBD Management. Authors' ReplyMaría José Casanova, María Chaparro, Javier P Gisbert
Inflammation & Allergy Drug Targets|November 1, 2012
Pathophysiological bases of eosinophilic esophagitis therapyRicardo Moreno-Borque, Javier P Gisbert, Cecilio Santander
Gastroenterologia Y Hepatologia|November 28, 2020
Epidemiological and clinical characteristics, and response to treatment in 113 patients with microscopic colitisEukene Rojo, María José Casanova, Javier P Gisbert
Alimentary Pharmacology & Therapeutics|June 7, 2024
Letter: Third-line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions-Authors' replyMaría José García, Javier P Gisbert, María Chaparro
Digestive Diseases and Sciences|September 12, 2006
The role of tacrolimus in inflammatory bowel disease: a systematic reviewYago Gonzalez-Lama, Javier P Gisbert, Jose Mate
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2025
Author's Reply: "Ustekinumab and vedolizumab: A step forward in managing complex perianal fistulas in Crohn's disease"María José Casanova, María Chaparro, Javier P Gisbert
Pageof 67